A detailed history of Quantum Private Wealth, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Quantum Private Wealth, LLC holds 38,661 shares of ITCI stock, worth $3.32 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares
38,661
Previous 38,261 1.05%
Holding current value
$3.32 Million
Previous $2.62 Million 7.86%
% of portfolio
1.0%
Previous 0.96%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$67.99 - $80.84 $27,195 - $32,336
400 Added 1.05%
38,661 $2.83 Million
Q2 2024

Jul 17, 2024

BUY
$64.76 - $79.84 $68,775 - $84,790
1,062 Added 2.85%
38,261 $2.62 Million
Q1 2024

May 07, 2024

BUY
$64.37 - $75.65 $868,608 - $1.02 Million
13,494 Added 56.92%
37,199 $2.57 Million
Q4 2023

Jan 30, 2024

BUY
$46.37 - $73.65 $431,611 - $685,534
9,308 Added 64.65%
23,705 $1.7 Million
Q3 2023

Nov 02, 2023

SELL
$52.09 - $64.1 $19,377 - $23,845
-372 Reduced 2.52%
14,397 $749,000
Q2 2023

Jul 27, 2023

SELL
$54.67 - $66.44 $6,833 - $8,305
-125 Reduced 0.84%
14,769 $935,000
Q1 2023

Apr 19, 2023

SELL
$43.8 - $56.99 $33,507 - $43,597
-765 Reduced 4.89%
14,894 $806,000
Q4 2022

Jan 20, 2023

SELL
$44.07 - $54.45 $41,469 - $51,237
-941 Reduced 5.67%
15,659 $0
Q3 2022

Nov 01, 2022

SELL
$42.7 - $59.99 $2.15 Million - $3.02 Million
-50,325 Reduced 75.2%
16,600 $772,000
Q2 2022

Aug 17, 2022

SELL
$43.0 - $65.64 $294,421 - $449,437
-6,847 Reduced 9.28%
66,925 $3.82 Million
Q1 2022

May 27, 2022

SELL
$38.74 - $62.09 $149,149 - $239,046
-3,850 Reduced 4.96%
73,772 $4.51 Million
Q4 2021

May 26, 2022

BUY
$35.2 - $53.42 $2.73 Million - $4.15 Million
77,622 New
77,622 $4.06 Million

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.12B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Quantum Private Wealth, LLC Portfolio

Follow Quantum Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantum Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantum Private Wealth, LLC with notifications on news.